What should I look for in CJC-1295 with DAC sourcing and quality?

Acceptable CJC-1295 with DAC certificates of analysis specify: lot-specific (not template) issuance, HPLC purity ≥98%, mass spec confirmation matching ~3367 Da, endotoxin testing for injectable routes, and third-party accredited laboratory issuance. Template COAs, missing endotoxin data, or vendor-internal labs are red flags. Pharmaceutical-grade compounded material is the lowest-risk supply path where accessible.

What does CJC-1295 with DAC stack well with?

For longevity / hallmarks of aging protocols, CJC-1295 with DAC pairs with compounds on complementary pathways: Epithalon, Thymalin, NAD+. These pairings are selected because they engage independent receptor systems from CJC-1295 with DAC's primary mechanism (Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release), producing additive or synergistic effects rather than receptor competition.

What is the standard dosing protocol for CJC-1295 with DAC?

Conventional CJC-1295 with DAC dosing is 1-2 mg 1-2x weekly via subq. For healthspan and biological-age use specifically, the cycle pattern is typically 8–12 weeks on followed by a 4 week off-period. Higher doses are studied in advanced protocols but produce diminishing dose-response in the published literature.

What is the evidence base for CJC-1295 with DAC?

CJC-1295 with DAC's evidence base sits at phase ii human data; widely used off-label. The references on this page summarise 2 primary publications supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The longevity / hallmarks of aging interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

How does CJC-1295 with DAC map to the hallmarks of aging?

CJC-1295 with DAC's longevity relevance maps to specific hallmarks based on its mechanism. Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release. The maleimide-based Drug Affinity Complex (DAC) tail covalently binds serum albumin, extending half-life from minutes to days. Stimulates pulsatile GH secretion that elevates baseline IGF-1. For users tracking healthspan-relevant biomarkers across cycles, the relevant endpoints are determined by which hallmark the compound primarily targets — telomere maintenance, senescence modulation, mitochondrial biogenesis, autophagy induction, inflammaging, or epigenetic clock effects. The framework above identifies the dominant contribution.

Home/ Compounds/ CJC-1295 with DAC

CJC-1295 with DAC

Longevity

For users tracking biological age and healthspan-relevant biomarkers, CJC-1295 with DAC sits within a multi-component longevity framework spanning hallmarks-of-aging from cellular (telomere, senescence, mitochondrial) through integrative (inflammaging, nutrient sensing). A long-acting growth-hormone-releasing-hormone analogue with a Drug Affinity Complex that extends half-life to roughly a week. Cycle-based dosing over 8-12 weeks with pre-post biomarker tracking is the longevity-research convention.

Longevity / Hallmarks of Aging Applications

Telomere SupportStem Cell FunctionNAD+ MetabolismmTOR ModulationHealthspan Extension

Key Takeaways

Longevity lens: CJC-1295 with DAC maps to specific hallmarks-of-aging endpoints rather than to acute clinical markers.
Mechanism: Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release.
Healthspan biomarkers: epigenetic age, telomere length, inflammatory markers, metabolic flexibility - all tracked across pre-post cycles.
Longevity protocol: cycle-based 1-2 mg 1-2x weekly dosing; 8-12 week cycles favoured over continuous administration.
Longevity stack partners: Epithalon, Thymalin, NAD+.

Longevity / Hallmarks of Aging Mechanism

Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release. The maleimide-based Drug Affinity Complex (DAC) tail covalently binds serum albumin, extending half-life from minutes to days. Stimulates pulsatile GH secretion that elevates baseline IGF-1. Healthspan-relevant interpretation of this mechanism asks which biomarkers move, in which direction, on what timescale. The subsections below cover the hallmark mapping, cellular and transcriptional effects, biomarker tracking, and the cycle structure favoured in longevity-research protocols for CJC-1295 with DAC.

Cycle-based versus continuous dosing

CJC-1295 with DAC's longevity protocol is compatible with either cycle-based or continuous dosing depending on the broader stack. The longevity-research convention favours pulsatile and periodic interventions over indefinite continuous administration, on the principle that hormetic stimulation outperforms sustained agonism for systems-biology-relevant endpoints.

Mapping to the hallmarks of aging

CJC-1295 with DAC's longevity relevance is best evaluated by mapping its mechanism to the hallmarks-of-aging framework. Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release. The maleimide-based Drug Affinity Complex (DAC) tail covalently binds serum albumin, extending half-life from minutes to days. Stimulates pulsatile GH secretion that elevates baseline IGF-1. This places its dominant contribution in the integrative hallmarks (systemic and inflammatory) layer of the framework, with secondary effects on adjacent hallmarks that combine to produce the broader healthspan-relevant phenotype.

Cellular reprogramming and gene expression

Where CJC-1295 with DAC has measurable effects on transcriptional programmes, the direction of effect tends to be toward younger phenotypes rather than away from them. This signature — partial reversal of age-associated expression changes — is what distinguishes a true longevity-relevant compound from a symptomatic one. The signal strength varies, but the direction is what longevity researchers track.

Longevity / Hallmarks of Aging Applications

Hallmarks of Aging

Hallmarks of Aging maps to one of the hallmarks of aging and is one of the dimensions on which CJC-1295 with DAC is evaluated in the longevity literature. Effect size on biomarkers varies across studies; the consistent finding is direction-of-effect rather than dramatic magnitude.

Senescence Modulation

CJC-1295 with DAC's contribution to senescence modulation as a longevity dimension is incremental rather than dramatic, consistent with the broader picture of healthspan-relevant peptides. The compound is best understood as one layer in a multi-component longevity protocol.

mTOR Modulation

For mtor modulation as a longevity-relevant endpoint, CJC-1295 with DAC is typically run in cycle-based protocols with paired pre-post biomarker measurement. Epigenetic age tracking, telomere length, and inflammatory panels are the standard outcome measures.

Inflammaging

Inflammaging maps to one of the hallmarks of aging and is one of the dimensions on which CJC-1295 with DAC is evaluated in the longevity literature. Effect size on biomarkers varies across studies; the consistent finding is direction-of-effect rather than dramatic magnitude.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	1-2 mg	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	1-2 mg	4–6 weeks initial cycle
Longevity focus	SubQ	1-2 mg	1-2x weekly
Maintenance phase	SubQ	1-2 mg	Ongoing with periodic pauses

Dose timing for CJC-1295 with DAC is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses. Fasted dosing produces stronger GH pulses; meal-paired dosing blunts the response.

Stacking

CJC-1295 with DAC stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from longevity researchers.

CJC-1295 with DAC + Epithalon: Identified by Khavinson in St. Pairs naturally with CJC-1295 with DAC's mechanism in longevity / hallmarks of aging protocols.
CJC-1295 with DAC + Thymalin: Influences T-cell maturation and immune function. Pairs naturally with CJC-1295 with DAC's mechanism in longevity / hallmarks of aging protocols.
CJC-1295 with DAC + NAD+: Coenzyme for over 500 enzymatic reactions including oxidative phosphorylation, glycolysis, fatty acid β-oxidation, and the citric acid cycle. Pairs naturally with CJC-1295 with DAC's mechanism in longevity / hallmarks of aging protocols.
CJC-1295 with DAC + MOTS-c: Translocates to the nucleus under metabolic stress and activates AMPK signalling. Pairs naturally with CJC-1295 with DAC's mechanism in longevity / hallmarks of aging protocols.

Safety & Regulatory Status

WADA: Banned (S2 class) FDA: Unapproved Research: Phase II human data; widely used off-label

Sustained IGF-1 elevation; monitor in users at risk of malignancy. Site reactions, transient flushing, water retention possible.

Lens-specific safety considerations for longevity / hallmarks of aging use of CJC-1295 with DAC: Sustained IGF-1 elevation; monitor in users at risk of malignancy. Site reactions, transient flushing, water retention possible. Additional longevity / hallmarks of aging monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

CJC-1295 sustained release of growth hormone in healthy adults

PMID 16940290

Supporting

Long-acting GHRH analogue mechanism and pharmacokinetics

PMID 16352683

CJC-1295 with DAC vs Related Peptides

Compound	Profile	Onset	Best For
CJC-1295 with DAC	Long-acting GHRH analogue	~6-8 days (with DAC)	Longevity
Epithalon	Pineal-derived tetrapeptide	Very short (minutes)	A pineal-derived tetrapeptide best known for telomerase upregulation and pineal-gland melatonin restoration in long-running rodent and human studies
Thymalin	Thymic polypeptide extract	Variable	A complex of low-molecular-weight thymic polypeptides used in Russian clinical research for decades — immunomodulation, anti-aging, and supportive care in chronic disease
MOTS-c	Mitochondrially-encoded peptide	Hours; tissue-distributed	A 16-amino-acid peptide encoded within mitochondrial DNA — discovered in 2015 and shown to regulate metabolic homeostasis, AMPK signalling, and insulin sensitivity
GHK-Cu	Tripeptide-copper complex	~30 min plasma	A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression

Frequently Asked Questions

Best stack pairing for longevity?

Layered protocols cover multiple hallmarks of aging simultaneously: pineal/telomere (epithalon), thymic/immune (thymalin), mitochondrial (MOTS-c, NAD+), ECM and gene expression (GHK-Cu), and metabolic flexibility (metformin-class or GLP-1-class as appropriate). CJC-1295 with DAC contributes to its specific hallmark layer in this multi-component framework.

How do I know if CJC-1295 with DAC is working?

Track outcome metrics that match the compound's primary mechanism: epigenetic age (DNA methylation panels), inflammatory markers (hsCRP, IL-6), metabolic flexibility (HbA1c, fasting insulin, HOMA-IR), body composition (DEXA), and subjective markers (sleep depth, recovery, well-being). Paired pre-post measurement around cycles is the standard framework.

When in life should I start CJC-1295 with DAC?

Most longevity-relevant peptides have evidence bases centred on mid-life and later. Earlier use is theoretically reasonable for users with documented age-related markers (elevated inflammation, accelerated epigenetic age) or for compounds whose mechanism is preventative. Below age 35 the benefit for most longevity peptides is theoretical and warrants compound-specific consideration.

Cycle-based or continuous dosing for longevity?

Longevity-research convention favours cycle-based and pulsatile interventions over indefinite continuous administration. Hormetic stimulation produces stronger systems-biology effects than sustained agonism for most longevity-relevant endpoints. CJC-1295 with DAC fits this framework with cycle lengths typical for its compound class.

What is CJC-1295 with DAC?

CJC-1295 with DAC (also known as CJC-1295 DAC / Long-acting GHRH) is a 30-residue long-acting ghrh analogue with a molecular weight of ~3367 Da and a plasma half-life of ~6-8 days (with DAC). Binds the GHRH receptor on somatotrophs to stimulate endogenous GH release. The maleimide-based Drug Affinity Complex (DAC) tail covalently binds serum albumin, extending half-life from minutes to days. Stimulates pulsatile GH secretion that elevates baseline IGF-1. The compound is studied primarily in the longevity / hallmarks of aging domain for the applications outlined above.

Is CJC-1295 with DAC safe during pregnancy or breastfeeding?

CJC-1295 with DAC, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

Clinical Protocol

Start a CJC-1295 with DAC Protocol

Alukard provides physician-supervised longevity protocols with GMP-certified CJC-1295 with DAC and GMP-certified compounds with biological age testing and healthspan markers.

Get Protocol

Quick Facts

Molecular weight: ~3367 Da
Sequence length: 30 aa
Half-life: ~6-8 days (with DAC)
WADA: Banned (S2 class)
FDA: Unapproved
Research: Phase II human data; widely used off-label

Stack Partners

Epithalon

Thymalin

NAD+

MOTS-c

GHK-Cu

Research Note

All longevity / hallmarks of aging applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for CJC-1295 with DAC unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised longevity protocols

Start Your Longevity / Hallmarks of Aging Protocol for CJC-1295 with DAC

Alukard provides physician-supervised longevity protocols with GMP-certified compounds with biological age testing and healthspan markers.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised